Background
==========

Addressing the unmet needs of individual rehabilitation of cancer patients is paramount.[@b1; @b2; @b3; @b4] The underlying problems are often psychological or social and many persist after treatment or emerge late in the illness continuum.[@b5; @b6; @b7; @b8] Rehabilitation is defined by WHO as 'a process intended to enable people with disabilities to reach and maintain optimal physical, sensory, intellectual, psychological and/or social function'[@b9] which is the conceptual frame for this study. Hence, rehabilitation is a complex and long-lasting process, but evidence on how and when to identify the patients\' needs, what initiatives to offer and how to manage the efforts is sparse.[@b2] [@b10; @b11; @b12; @b13]

General practice is characterised by continuity with frequent encounters with each patient, covering wide-ranging issues.[@b14] Hence, general practitioners (GPs) generally have profound knowledge about the patients\' prior health status, mental vulnerability and social network. General practice may, therefore, be able to initiate the rehabilitation process and take on the task of coordinating or providing the rehabilitation services needed, but currently the role of GPs is not well defined.[@b15; @b16; @b17; @b18; @b19; @b20; @b21; @b22; @b23] Studies do, however, show that GPs are willing to undertake these tasks and that the patients wish that their GPs were more proactive in doing so.[@b21] [@b24]

The objective of this trial was to investigate the effect of a multimodal intervention giving the GP an enhanced role in improving patients\' health-related quality of life and psychological distress following cancer. To validate our results, we conducted subgroup analyses of the large and homogeneous group of breast cancer patients.

Material and methods
====================

We conducted a cluster randomised controlled trial, where all general practices in Denmark were randomised to an intervention group or to a control group by means of the unique provider number of each practice. Patients were subsequently allocated according to the randomisation of their GP. Feasibility of the intervention and the study details has previously been published.[@b25]

Participants
------------

All adult patients (≥18 years) newly diagnosed as having cancer and admitted to Vejle Hospital between 12 May 2008 and 28 February 2009 were assessed for eligibility. Patients were included if treated at Vejle Hospital for a cancer diagnosed within the last 3 months and if listed with a general practice. Patients with carcinoma in situ or non-melanoma skin cancers were not included ([figure 1](#fig1){ref-type="fig"}).
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Two rehabilitation coordinators, both nurses with oncological experience, assessed all patients for eligibility and managed the intervention. The patients were sampled across departments, type of cancer, stage and potential rehabilitation needs by use of the electronic patient files.[@b25]

Setting
-------

The study was conducted at Vejle Hospital, a public general hospital in the region of Southern Denmark (1.2 million inhabitants).[@b26] Cancer patients were allocated from all departments treating cancer at Vejle Hospital, and could in principle be residents from all parts of Denmark.

The Danish publicly funded healthcare system ensures free access to general practice, which is responsible for primary care needs, and GPs function as gatekeepers to the rest of the healthcare system. More than 98% of all Danish residents are registered with a general practice. On average, each GP meets nine incident cancer patients during 1 year.[@b27]

GPs\' opportunities to refer patients to relevant rehabilitation services vary between the different municipalities, just as the availability of private patient associations and other relief organisations. These conditions might influence the quality of the rehabilitation interventions offered.

The intervention
----------------

The intervention comprised a patient interview about rehabilitation needs performed by the rehabilitation coordinators, followed by information to the GP about the patient\'s individual rehabilitation needs and cancer patients\' rehabilitation needs in general. The core of the information was that the GP was encouraged to contact the patient to facilitate a rehabilitation process ([table 1](#tbl1){ref-type="table"}).

###### 

General needs and problems among cancer patients

  --------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Psychological level   Fear of death or recurrenceGuilt feelings about being sickAnger at general practitioner or 'system' for not having taken action soon enoughTroubles adjusting to new self-imageSense of being left in limbo after discharge from the hospitalRisk of developing depressionReconsiderations about priorities in life and how one wants to live life with or after a cancer diseaseSexual problems
  Social level          Concerns about the well-being of spouse, children and other relativesChanged body image or sexualityChanged position/status in marriage, in family, at work, etcConcerns about possible infertility caused by treatmentInformation about patient associations and similar groups for patients and relatives
  Physical level        Physical capacity according to daily activities, need for special facilities, home care, conversions of the home, etcNeed for dietary advice, for example, to prevent undue weight lossSupport in order to accept physical changes and late complications like tiredness, amputation, infertility, pain, etc
  Work-related level    Concerns about losing one\'s jobConcerns about having to give up one\'s former responsibilities or change field of work due to reduced ability to workOpportunities for financial support during sick-leave, flexible job, etcSupport to keep in contact with workplace during sick-leave
  Financial level       Social rights like mileage allowances, reimbursement of assistive technology, etcConcerns about a decrease in income and consequences hereof in relation to housing, spouse, children, etcConditions regarding pension or incapacity benefit
  --------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

The patient interviews were conducted according to an interview guide[@b28] and based on a checklist of general needs and problems among cancer patients ([table 1](#tbl1){ref-type="table"}). Interviews were most often conducted at the hospital but in some cases, by phone. During the interview, the concept of rehabilitation was explained and the individual needs for physical, psychological, sexual, social, work-related and economy-related rehabilitation were identified. It was explained that physical, psychological, sexual, social, work-related and financial issues[@b1; @b2; @b3; @b4] [@b29] might occur at any time and change during the disease trajectory.[@b7] [@b8] In order to address these problems, patients were advised to consult their GP during treatment and after discharge. The patients gave oral consent first to their GPs being informed as to their individual problems and needs and second to their GPs being encouraged to be proactive regarding the patients\' rehabilitation.

Following each interview, the patient\'s GP was informed about the patient\'s actual problems and needs for rehabilitation and encouraged to be proactive, that is, the GP was encouraged to contact the patient personally to offer support and guidance in order to identify and address actual and future needs for rehabilitation. Subsequently, the GP received an email summarising the information, supplemented by general information about cancer patients\' needs and problems ([table 1](#tbl1){ref-type="table"}). The information was personally conveyed by phone, if possible, and always sent electronically along with the more general information. Patients and GPs in the control group received the usual care and were not contacted by the rehabilitation coordinators.[@b25]

Outcomes and sampling of data
-----------------------------

The primary outcome was health-related quality of life measured 6 months after inclusion using the Global Health Status of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30).[@b30] [@b31] The secondary outcomes were psychological distress at 14 months assessed by the six scales of the Profile of Mood States[@b32] (depression/dejection, anger/hostility, tension/anxiety, vigour/activity, fatigue/inertia and confusion/bewilderment) and the Global Health Status at 6 months and functional (physical, emotional, role, cognitive or social functioning) and symptom scales (fatigue, nausea/vomiting, pain, dyspnoea, insomnia, appetite loss, constipation, diarrhoea or financial difficulties) of the EORTC QLQ-C30 at 6 and 14 months.

Data were sampled in identical ways irrespective of allocation status by use of patient questionnaires administered to patients alive at 6 and 14 months after inclusion. Non-responders were sent one reminder after 3 weeks.[@b25]

Sample size
-----------

The sample size was estimated based on the primary outcome measure. According to the EORTC Tables of Reference Values[@b33] for all cancer patients, all stages, the Global Health Status is normally distributed with a mean of 61.3 and an SD of 24.2. A change of at least 8 units was assumed to be clinically relevant.[@b33] [@b34]

If the lowest acceptable statistical power was 80%, then, based on the two-sample t test with a type 1 error α=0.05, the sample size was calculated to be 144 patients per group. The study was subject to clustering because the unit of randomisation was at the level of the GP, whereas the primary outcome measure was at the level of the patient. A strong effect on outcome of the individual practice was expected, but no data supported estimation of cluster effect. To allow maximum clustering, it was attempted to include patients to each group from a minimum of 144 practices.

Randomisation
-------------

Prior to study start, all 2181 general practices in Denmark were randomly allocated to the intervention (n=1091) or control (n=1090) group by the unique provider number of each practice using a computerised random-number generator in the statistical program Stata V.10.0 (StataCorp). Hence, randomisation was performed at practice level meaning that all GPs working under the same provider number were allocated to the same group. Consequently, spillover effect between GPs and patients from the same practice was minimised.

Blinding
--------

The study was not blinded. The list of randomisation was available to the RCs during assessment of patient eligibility. Allocation status was obvious during intervention.

Statistical analysis
--------------------

Baseline patient characteristics were described using descriptive statistics in order to present the distribution of age, sex and cancer type. We conducted intention to treat analyses, and numerical outcomes of the randomised controlled trial were analysed using a multilevel linear model, accounting for possible cluster effects caused by the cluster randomisation. All secondary outcomes were adjusted for confounding effect of age and sex. Missing values were regarded as missing at random. We conducted complete case analyses.

The statistical analyses were performed using Stata V.11.0 (StataCorp.).

Development and piloting of questionnaires and intervention
-----------------------------------------------------------

Before designing the intervention, we reviewed papers, reports and textbooks about the problems faced by cancer patients and GPs with respect to individual rehabilitation and continuity across healthcare sectors.[@b1; @b2; @b3] [@b16; @b17; @b18; @b19; @b20; @b21; @b22; @b23; @b24] [@b35]

The questionnaires and the procedures of identification, assessment and inclusion of patients were pilot tested prior to study start. The procedures have been described in detail.[@b25]

Results
=======

In total, 955 patients fulfilled the criteria for inclusion and 486 patients were allocated to the intervention group and 469 to the control group ([figure 1](#fig1){ref-type="fig"}). The patients were registered with 323 general practices. Patients were on average aged 63 years at baseline and 72% were women. The most frequent cancer localisations were breast (43%) and lung (15%). The intervention and control groups showed similar baseline characteristics ([table 2](#tbl2){ref-type="table"}). For the primary outcome, Global Health Status at 6 months, we obtained data from 281 patients from 131 practices in the intervention group and 297 patients from 125 practices in the control group, in total 612 of 858 (71%) patients (95% CI for ICC 0.000 to 0.103). The percentage of missing data in the primary outcome was 5.6% (similar in the intervention and control groups).

###### 

Baseline demographic and medical characteristics for all included patients (n=955)

  Demographic characteristics   Control group (n=469)   Intervention group (n=486)
  ----------------------------- ----------------------- ----------------------------
  Age, years                                            
   Mean (CI)                    63.6 (62.5 to 64.6)     63.2 (62.2 to 64.3)
   Median                       64                      64
   Range                        21--98                  28--92
  Sex                                                   
   Male, n (%)                  134 (28.6)              133 (27.4)
   Female, n (%)                335 (71.4)              353 (72.6)
  Cancer type                   n (%)                   n (%)
   Cancer of breast             206 (43.9)              201 (41.4)
   Cancer of lung               69 (14.7)               75 (15.4)
   Malignant melanoma           44 (9.4)                35 (7.2)
   Cancer of rectum/anus        33 (7.0)                45 (9.3)
   Cancer of colon              29 (6.2)                39 (8.0)
   Cancer of ovaries            12 (2.6)                9 (1.9)
   Cancer of biliary system     7 (1.5)                 8 (1.6)
   Cancer of brain              6 (1.3)                 8 (1.6)
   Cancer of prostate           8 (1.7)                 3 (0.6)
   Cancer of corpus uteri       6 (1.3)                 5 (1.0)
   Myelomatosis                 6 (1.3)                 5 (1.0)
   Lymphoma                     3 (0.6)                 4 (0.8)
   Unspecified location         16 (3.4)                16 (3.3)
   Other diagnoses              24 (5.1)                33 (6.8)

The intervention had no statistically significant impact on the primary or on the secondary outcomes ([tables 3](#tbl3){ref-type="table"} and [4](#tbl4){ref-type="table"}). Adjustment for age and sex of the secondary outcomes showed results similar to the unadjusted analysis. Intention to treat analyses on all outcomes of the group of breast cancer patients showed no statistical differences between patients in the intervention and control groups (mean difference in primary outcome of 1.77 (−3.2 to 6.8)). Per-protocol analyses on all outcomes were used to analyse if the personal telephone contact to the GP was crucial. The patients receiving all elements of the intervention showed no statistically significant difference when compared with the control group (mean difference in primary outcome of −4.43 (−9.7 to 0.8)).

###### 

Health-related quality of life (EORTC QLQ-C30) outcome variables and mean differences at 6 and 4 months (95% CI)

  Outcome variable                       6 months   14 months                                                                                            
  -------------------------------------- ---------- --------------------- --------------------- ------ ----- --------------------- --------------------- ------
  Global health status/quality of life                                                                                                                   
   Control group                         297        68.0 (65.5 to 70.5)                                246   72.8 (70.3 to 75.3)                         
   Intervention group                    281        69.3 (66.7 to 71.9)   1.25 (−2.4 to 4.9)    0.50   240   72.1 (69.6 to 74.7)   −0.71 (−4.3 to 2.8)   0.69
  Physical functioning                                                                                                                                   
   Control group                         294        79.0 (76.4 to 81.5)                                240   81.9 (79.3 to 84.5)                         
   Intervention group                    280        79.7 (77.1 to 82.4)   0.77 (−2.9 to 4.4)    0.68   234   82.0 (79.4 to 84.6)   −0.08 (−3.6 to 3.8)   0.97
  Role functioning                                                                                                                                       
   Control group                         291        71.3 (67.7 to 74.9)                                239   78.0 (74.4 to 81.7)                         
   Intervention group                    277        72.5 (68.8 to 76.1)   1.18 (−3.9 to 6.3)    0.65   235   78.8 (75.0 to 82.5)   0.70 (−4.5 to 5.9)    0.79
  Emotional functioning                                                                                                                                  
   Control group                         293        80.5 (78.1 to 83.0)                                240   80.7 (77.9 to 83.4)                         
   Intervention group                    278        81.6 (79.1 to 84.1)   1.02 (−2.5 to 4.5)    0.57   238   80.8 (78.0 to 83.6)   0.12 (−3.8 to 4.1)    0.95
  Cognitive functioning                                                                                                                                  
   Control group                         290        83.0 (80.5 to 85.5)                                245   82.6 (79.7 to 85.5)                         
   Intervention group                    278        83.9 (81.3 to 86.4)   0.88 (−2.7 to 4.5)    0.63   238   85.1 (82.1 to 88.2)   2.53 (−1.7 to 6.7)    0.24
  Social functioning                                                                                                                                     
   Control group                         295        85.7 (83.0 to 88.4)                                242   88.2 (85.4 to 91.0)                         
   Intervention group                    280        86.0 (83.2 to 88.8)   0.28 (−3.6 to 4.2)    0.89   238   87.4 (84.6 to 90.3)   −0.77 (−4.8 to 3.2)   0.71
  Fatigue                                                                                                                                                
   Control group                         292        37.4 (34.3 to 40.6)                                244   32.1 (28.8 to 35.3)                         
   Intervention group                    279        34.2 (30.9 to 37.4)   −3.27 (−7.8 to 1.3)   0.16   234   32.3 (28.9 to 35.6)   0.23 (−4.5 to 4.9)    0.92
  Nausea and vomiting                                                                                                                                    
   Control group                         300        8.1 (6.1 to 10.0)                                  244   5.5 (3.9 to 7.2)                            
   Intervention group                    284        8.0 (6.0 to 10.0)     −0.11 (−2.9 to 2.7)   0.94   236   5.6 (3.9 to 7.3)      0.05 (−2.3 to 2.4)    0.97
  Pain                                                                                                                                                   
   Control group                         283        23.0 (19.8 to 20.2)                                241   21.9 (18.5 to 25.4)                         
   Intervention group                    274        22.0 (18.8 to 25.3)   −0.95 (−5.5 to 3.6)   0.68   234   21.4 (17.8 to 24.9)   −0.56 (−5.5 to 4.4)   0.83
  Dyspnoea                                                                                                                                               
   Control group                         297        17.0 (13.9 to 20.2)                                245   13.2 (10.0 to 16.5)                         
   Intervention group                    286        17.9 (14.7 to 21.2)   0.87 (−3.6 to 5.4)    0.71   233   15.4 (11.9 to 18.8)   2.11 (−2.6 to 6.8)    0.38
  Insomnia                                                                                                                                               
   Control group                         302        27.5 (24.0 to 31.0)                                248   29.6 (25.6 to 33.6)                         
   Intervention group                    285        27.3 (23.6 to 30.9)   −0.23 (−5.3 to 4.8)   0.93   240   28.5 (24.4 to 32.6)   −1.08 (−6.8 to 4.6)   0.71
  Appetite loss                                                                                                                                          
   Control group                         301        14.1 (11.0 to 17.2)                                246   9.6 (7.1 to 12.2)                           
   Intervention group                    288        15.9 (12.7 to 19.0)   1.79 (−2.7 to 6.2)    0.43   239   7.9 (5.4 to 10.5)     −1.67 (−5.3 to 2.0)   0.37
  Constipation                                                                                                                                           
   Control group                         299        12.6 (9.7 to 15.5)                                 248   11.9 (9.0 to 14.91)                         
   Intervention group                    284        11.3 (8.3 to 14.2)    −1.33 (−5.4 to 2.8)   0.53   236   8.9 (5.9 to 11.9)     −3.03 (−5.5 to 2.8)   0.16
  Diarrhoea                                                                                                                                              
   Control group                         299        11.3 (8.8 to 13.9)                                 250   11.4 (8.5 to 14.2)                          
   Intervention group                    284        11.4 (8.8 to 14.1)    0.08 (−3.6 to 3.8)    0.97   238   10.0 (7.0 to 13.0)    −1.38 (−5.5 to 2.8)   0.51
  Financial difficulties                                                                                                                                 
   Control group                         297        7.6 (5.4 to 9.8)                                   242   6.5 (3.9 to 9.0)                            
   Intervention group                    284        8.0 (5.7 to 10.2)     0.34 (−2.8 to 3.5)    0.83   236   6.7 (4.1 to 9.4)      0.27 (−3.4 to 4.0)    0.89

Mean values from 0 to 100. A score of 100 indicates optimal function or maximum symptom intensity (ie, for functional measures, an increase indicates improvement, while for symptoms, an increase indicates worsening).

EORTC QLQ-C30, European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30.

###### 

Psychological distress (POMS) at 14 months and mean differences between groups (95 CI%)

  Outcome variable         n     Mean range   Mean (95% CI)           Mean difference (95% CI)   p Value
  ------------------------ ----- ------------ ----------------------- -------------------------- ---------
  Anger/hostility                0--28                                                           
   Control group           223                2.03 (1.59 to 2.48)                                
   Intervention group      230                1.88 (1.43 to 2.33)     −0.15 (−0.79 to 0.48)      0.64
  Confusion/bewilderment         0--20                                                           
   Control group           229                2.45 (2.04 to 2.86)                                
   Intervention group      231                2.11 (1.69 to 2.53)     −0.34 (−0.92 to 0.25)      0.26
  Depression/dejection           0--32                                                           
   Control group           223                3.85 (3.20 to 4.51)                                
   Intervention group      229                3.26 (2.61 to 3.92)     −0.59 (−1.52 to 0.34)      0.21
  Fatigue/inertia                0--20                                                           
   Control group           226                4.65 (4.08 to 5.22)                                
   Intervention group      234                4.14 (3.02 to 4.10)     −0.51 (−1.32 to 0.29)      0.21
  Tension/anxiety                0--24                                                           
   Control group           226                3.82 (3.28 to 4.36)                                
   Intervention group      233                3.56 (3.02 to 4.10)     −0.26 (−1.02 to 0.50)      0.50
  Vigour/activity                0--24                                                           
   Control group           218                10.28 (9.51 to 11.05)                              
   Intervention group      228                10.09 (9.31 to 10.86)   −0.20 (−1.29 to 0.89)      0.72
  Total mood disturbance         0--124                                                          
   Control group           200                4.87 (2.29 to 7.45)                                
   Intervention group      210                4.19 (1.62 to 6.76)     −0.68 (−4.32 to 2.97)      0.72

Mean values of each subscale depends on the number of items related to the individual subscale which varies from 5 to 8, each item ranging from 0 to 4. Total mood disturbance is calculated by summing up the scores on the five negative symptom subscales and subtracting the score on the one positively scored subscale, vigour/activity. A higher score indicates a higher degree of symptoms/feelings within the related subscale.

POMS, Profile of Mood States.

Discussion
==========

Principal findings
------------------

This intervention including a hospital-based patient interview about rehabilitation, individual and general information to the GP and an encouragement to contact the patient and facilitate a process of rehabilitation did not improve quality of life or relieve psychological distress of patients newly diagnosed as having cancer.

Strengths and weaknesses of the study
-------------------------------------

The study included 955 patients and the pre-study power calculation and the precision of the statistical estimates indicate that the study could have detected relevant effects of the intervention. The CI of the difference in global health status after 6 months ranged between −2.4 and 4.9 units. Clinically relevant differences have been suggested to correspond to at least 8 units.[@b33] [@b34]

An important question is whether any spillover effects may have improved care for the patients in the control group, leading to an apparently smaller impact of the intervention. Information about the study and the concept of rehabilitation was given to the staff at the involved departments at Vejle Hospital during the inclusion period, but the intervention was managed by the two rehabilitation coordinators without influence on the care provided for the patients in the control group. The cluster randomisation was performed to ensure that GPs only cared for patients in either the intervention or the control group. GPs in the control group were not informed about the study, and we have no reason to believe that information about the study was disseminated between GPs in the two groups.

Another question is whether we used the most relevant outcome measures. Process measures are often used to evaluate interventions. However, despite successful implementation of interventions, the impact on patients\' well-being is often sparse. Hence, we deliberately chose patients\' quality of life as the primary outcome. Furthermore, the EORTC QLQ-C30 and the Profile of Mood States questionnaires are well-validated instruments to evaluate change of quality of life in cancer patients and psychological distress in general.[@b30; @b31; @b32; @b33; @b34]

The intervention was designed to support rehabilitation irrespective of the character of the problem, cancer type, age and sex. We included patients with various cancer types, different prognosis, health problems and needs of supportive care. The inhomogeneity of the study population might have diluted effects in groups of patients with specific problems or diagnoses. It cannot be ruled out that a similar intervention might have effect on subgroups of patients with specific cancers or special needs. However, no effect was observed when analysing the large and rather homogeneous group of breast cancer patients.

The intervention included a personal telephone contact to the patients\' GP but some GPs were not reachable.[@b25] A priori we assumed that this personal contact could be of major importance, but per-protocol analysis showed no differences in outcomes for patients where the rehabilitation coordinators managed to reach the GP by phone.

Relations to other studies
--------------------------

To our knowledge, only three papers have specifically evaluated the impact of GP involvement in cancer rehabilitation in a randomised design.[@b17] [@b35] [@b36] A shared care programme (n=250) conducted in Denmark in 2003 included transfer of knowledge from oncologists to GPs, improved communication between parties and active patient involvement.[@b17] This intervention had a positive impact on patient evaluation of cooperation between primary and secondary healthcare sectors but not on quality of life. A Norwegian study from 2005 (n=91) evaluated the effect of an invitation to a 30 min consultation with the patient\'s GP, aiming at creating a closer and more frequent contact between patients and GPs.[@b35] No increase in number of consultations or improvement of quality of life was observed. The latest study was conducted in Sweden in 2008 (n=481) and tested the effectiveness of individual support, group rehabilitation and a combination of the two compared with standard care.[@b36] The individual support included individual psychological and nutritional support along with intensified primary healthcare, including extended information about the diagnosis, education in cancer care and supervision of the patient\'s home care nurse and GP by a multiprofessional oncology team. The Swedish study did not show an improvement either in quality of life or psychological well-being when compared with standard care. Furthermore, a systematic review[@b37] including the three studies concluded that none of the interventions improved quality of life or patient well-being, but due to possible methodological problems, further studies on the topic are needed.

Meaning
-------

Interventions aiming to give the GP an enhanced role in cancer rehabilitation seem to have difficulties improving quality of life. Furthermore, a number of papers evaluating the effect of various other types of interventions aiming to improve quality of life of cancer patients[@b38; @b39; @b40; @b41; @b42; @b43] have demonstrated that this may be difficult in general. To better understand the intervention and the impact on GP and patient behaviour, further studies will include evaluation of process measures like GP proactivity, patient participation in different rehabilitation activities and GP and patient satisfaction.

Future studies should evaluate the importance of the organisation of cancer treatment and rehabilitation. Is an unclear organisation with many partners (hospital departments, GPs, municipalities and private organisations) an impediment to effective rehabilitation? A well-organised system with defined roles and easy referral to various elements of rehabilitation (specialised physiotherapy, social counselling, psychological advice etc.) may be of importance for the effect of a GP intervention. To improve rehabilitation, it may also be important to develop screening tools that support identification of patients with special needs. Initiatives supporting the GPs in undertaking a proactive role for patients with special needs should be considered. The effect of interventions should, however, be carefully evaluated in order to ensure efficient use of resources before implementation.
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